Medical Equipment & Devices

FNArena Windows (Sectors)

Introduction to FNArena Windows

FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.

Latest Stories

Lack of competition, alongside improved component supply, sees ResMed deliver a strong second quarter

Jan 31 2023

Following a change to a direct distribution model, Nanosonics has delivered a better than expected first half, but brokers remain cautious

Jan 24 2023


ASX CODE COMPANY NAME LAST PRICE 52WK HIGH 52WK LOW P/E CONSENSUS TARGET
CBL CONTROL BIONICS LIMITED $0.18 $0.46 $0.12

$0.85

COH COCHLEAR LIMITED $212.50 $236.43 $184.62 47.3

$215.783

EBR EBR SYSTEMS INC $0.63 $0.83 $0.33

$0.987

FPH FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED $23.61 $28.89 $16.11 64.6

$21.75

IDX INTEGRAL DIAGNOSTICS LIMITED $3.17 $4.28 $2.38 27.3

$2.804

IME IMEXHS LIMITED $0.40 $xx.xx $xx.xx xx.x xx.xx
IPD IMPEDIMED LIMITED $0.06 $xx.xx $xx.xx xx.x xx.xx
MX1 MICRO-X LIMITED $0.14 $xx.xx $xx.xx xx.x xx.xx
NAN NANOSONICS LIMITED $4.81 $xx.xx $xx.xx xx.x xx.xx
PME PRO MEDICUS LIMITED $65.37 $xx.xx $xx.xx xx.x xx.xx
RMD RESMED INC $32.23 $xx.xx $xx.xx xx.x xx.xx
SOM SOMNOMED LIMITED $1.23 $xx.xx $xx.xx xx.x xx.xx
TRJ SOMNOMED LIMITED $1.86 $xx.xx $xx.xx xx.x xx.xx
VHT VOLPARA HEALTH TECHNOLOGIES LIMITED $0.81 $xx.xx $xx.xx xx.x xx.xx
Previous Stories
Nanosonics Recovers On Less Negative Sentiment

Nov 29 2022

A turn in sentiment has allowed Nanosonics shares to recover, with (some) broker views turning less negative


Treasure Chest: Fisher & Paykel Healthcare

Nov 16 2022

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Fisher & Paykel Healthcare


Dr Boreham’s Crucible: Imricor Medical Systems

Oct 17 2022

Imricor is a player in a global catheter ablation market worth $US5.5 billion and growing at a compound rate of just over 8% a year


Market Share Gains Key to ResMed’s Outlook

Aug 15 2022

Following FY22 results, brokers set higher price targets for ResMed on average and expect market share gains


Dr Boreham’s Crucible: 4D Medical

Aug 08 2022

Dedicated lung imaging pioneer 4D medical sees itself as a software company, with lots of future potential, including from the US military


Treasure Chest: The Outlook For Cochlear

Jul 27 2022

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea regards Cochlear


Nanosonics’ Q4 Surprises, But Brokers See Risk

Jul 27 2022

Nanosonics’ June quarter update proved a positive surprise but most brokers cannot get past the many risks, also finding the shares look expensive


Benefits In View For Radiology AI Adopters

Jul 11 2022

After a huge step up in funding over the last three years, artificial intelligence in radiology may be approaching wider adoption across the sector


Brokers Divided Over ResMed’s SaaS Acquisition

Jun 16 2022

Following ResMed’s purchase of Medifox Dan, brokers remain upbeat though some question the benefits of SaaS acquisitions to date


Shortages Chip Away At ResMed’s Big Break

Mar 30 2022

ResMed has struggled to realise the benefit promised by a major competitor recall and heightened demand amid a global shortage of semiconductor chips necessary for device production